Every day, thousands of Indonesians donate blood and plasma, often unaware of the complex scientific and safety-driven ...
Not intended for the UK Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with ...
1hon MSN
Fecal transplant capsules show promising results in clinical trials for multiple types of cancer
Fecal microbiota transplants (FMT) can dramatically improve cancer treatment, suggest two groundbreaking studies published in ...
Detailed price information for U S Antimony Corp (UAMY-A) from The Globe and Mail including charting and trades.
"The Critical Minerals and ZEO Company"~ Antimony, Cobalt, Tungsten, and Zeolite ~ DALLAS, TX / ACCESS Newswire / January 28, 2026 / United States Antimony Corporation ("USAC," "US Antimony," or the " ...
Boehringer Ingelheim has reported encouraging Phase II trial results for apecotrep (BI 764198), a potential first-in-class oral TRPC6 inhibitor being developed for primary focal segmental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results